LEU | Ticker Profile - Titan Protect

LEU

Centrus Energy Corp.

Energy · Uranium · NYQ

$161.78

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$3.5B

Total market value of the company

Trailing P/E

65.26

Expensive — high growth expected

Forward P/E

45.37

Based on estimated future earnings — lower means cheaper

Rev Growth

+4.9%

Year-over-year revenue change

Profit Margin

13.4%

How much profit the company keeps from each dollar of revenue

ROE

12.3%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$290.00

+79% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 14 analysts covering this stock

About Centrus Energy Corp.

Centrus Energy Corp. supplies nuclear fuel components for the nuclear power industry in the United States, Belgium, Japan, the Netherlands, and internationally. The company operates in two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants. The Technical Solutions segment offers technical, manufacturing, engineering, and operations services to public and private sector customers. The company was formerly known as USEC Inc. and changed its name to Centrus Energy Corp. in September 2014. Centrus Energy Corp. was incorporated in 1998 and is headquartered in Bethesda, Maryland.

https://www.centrusenergy.com

Country: United States Employees: 467 Industry: Uranium

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

1.171

Excellent risk-adjusted returns

Kelly Fraction

0.0917

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.548

Returns exceed worst-case losses — strong risk profile

Annual Return

95.0%

Historical annualised return based on price data

Max Drawdown

-61.4%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.44

Moves slightly more than the broader market

52W High

$464.25

65% below the year high

52W Low

$117.64

38% above the year low

Avg Volume

844,003

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.5

Days it would take all short sellers to cover — higher means more crowded

Short % Float

22.6%

Very high short interest — potential squeeze candidate

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$2.76

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

152.04

Heavy leverage — higher financial risk if revenues decline

Current Ratio

5.72

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

4.76

Like current ratio but excludes inventory — stricter test

Gross Margin

25.7%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-0.3%

Profit from core operations before interest and tax

Free Cash Flow

$-10,875,000

Negative — the business is spending more than it generates

Revenue (TTM)

$452M

Total revenue over the last 12 months

Net Income

$61M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$390.00

Target Median

$290.00

Target Low

$195.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go